The openness of pluripotent epigenome - Defining the genomic integrity of stemness for regenerative medicine

Xuejun H Parsons

Abstract


This article is an editorial, and it doesn't include an abstract. Full text of this article is available in HTML and PDF.

Cite this article as: Parsons XH. The openness of pluripotent epigenome - Defining the genomic Integrity of stemness for regenerative medicine. Int J Cancer Ther Oncol 2014; 2(1):020114.

DOI: http://dx.doi.org/10.14319/ijcto.0201.14


Full Text:

PDF HTML

References


Parsons XH, Teng YD, Moore DA, Snyder EY. Patents on Technologies of Human Tissue and Organ Regeneration from Pluripotent Human Embryonic Stem Cells. Rec Pat Regen Med 2011; 1: 142-163.

Parsons XH. Constraining the pluripotent fate of human embryonic stem cells (hESCs) for tissue engineering and cell therapy - the turning point of cell-based regenerative medicine. British Biotech J 2013; 3: 424-457.

Parsons XH. Embedding the future of regenerative medicine into the open epigenomic landscape of pluripotent human embryonic stem cells. Ann Rev Res Biol 2013; 3: 323-349.

Parsons XH. Human Stem Cell Derivatives Retain More Open Epigenomic Landscape When Derived from Pluripotent Cells than from Tissues. J Regen Med 2013; 1: 1000103.

Parsons XH. An engraftable human embryonic stem cell neuronal lineage-specific derivative retains embryonic chromatin plasticity for scale-up CNS regeneration. J Reg Med & Tissue Eng 2012; 1: 3.

Parsons JF, Smotrich DB, Gonzalez R, Snyder EY, Moore DA, Parsons XH. Defining Conditions for Sustaining Epiblast Pluripotence Enables Direct Induction of Clinically-Suitable Human Myocardial Grafts from Biologics- Free Human Embryonic Stem Cells. J Clin Exp Cardiolog 2012; S9-001.

Parsons XH. The Dynamics of Global Chromatin Remodeling are Pivotal for Tracking the Normal Pluripotency of Human Embryonic Stem Cells. Anat Physiol 2012; S3:002.

Parsons XH, Teng YD, Parsons JF, Snyder EY, Smotrich DB, Moore DA. Efficient derivation of human cardiac precursors and cardiomyocytes from pluripotent human embryonic stem cells with small molecule induction. J Vis Exp 2011; 57:e3274.

Parsons XH, Teng YD, Parsons JF, Snyder EY, Smotrich DB, Moore DA. Efficient derivation of human neuronal progenitors and neurons from pluripotent human embryonic stem cells with small molecule induction. J Vis Exp 2011; 56:e3273.

Parsons XH. MicroRNA profiling reveals distinct mechanisms governing cardiac and neural lineage-specification of pluripotent human embryonic stem cells. J Stem Cell Res Ther 2012; 2:124.

Parsons XH, Parsons JF, Moore DA. Genome-scale mapping of microRNA signatures in human embryonic stem cell neurogenesis. Mol Med Ther 2012; 1:105.

Parsons XH. Mending the broken heart - Towards clinical application of human embryonic stem cell therapy derivatives. J Clin Exp Cardiolog 2012; 3:e116.

Parsons XH. Cellular medicine for the heart - the pharmacologic utility and capacity of human cardiac stem cells. J Clin Exp Cardiolog 2013; S11-e001.

Parsons XH. Exploring future cardiovascular medicine: heart precursors directed from human embryonic stem cells for myocardium regeneration. Cardiol Pharmacol 2013; 2:e110.

Parsons XH. Reviving cell-based regenerative medicine for heart reconstitution with efficiency in deriving cardiac elements from pluripotent human embryonic stem cells (Editorial). Cardiol Pharmacol 2013; 2:e112.




DOI: http://dx.doi.org/10.14319/0201.14

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.

------------------------------------------------------------

International Journal of Cancer Therapy and Oncology (ISSN 2330-4049)

© International Journal of Cancer Therapy and Oncology (IJCTO)

To make sure that you can receive messages from us, please add the 'ijcto.org' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders.

------------------------------------------------------------

Number of visits since October, 2013
AmazingCounters.com